Attached files
file | filename |
---|---|
10-Q - FORM 10-Q - SCOLR Pharma, Inc. | form_10-q.htm |
EX-32.1 - EXHIBIT 32.1 - CEO CERTIFICATION - SCOLR Pharma, Inc. | exhibit_32-1.htm |
EX-31.2 - EXHIBIT 31.2 - CFO CERTIFICATION - SCOLR Pharma, Inc. | exhibit_31-2.htm |
EX-31.1 - EXHIBIT 31.1 - CEO CERTIFICATION - SCOLR Pharma, Inc. | exhibit_31-1.htm |
EX-10.4 - EXHIBIT 10.4 - SCOLR Pharma, Inc. | exhibit_10-4.htm |
EX-10.6 - EXHIBIT 10.6 - SCOLR Pharma, Inc. | exhibit_10-6.htm |
EX-10.3 - EXHIBIT 10.3 - SCOLR Pharma, Inc. | exhibit_10-3.htm |
EXHIBIT
32.2
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report of SCOLR Pharma, Inc. (the “Company”) on
Form 10-Q for the period ended September 30, 2009, as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), I, Richard M. Levy,
Chief Financial Officer and Vice President – Finance of the Company, certify,
pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley
Act of 2002, that, to the best of my knowledge:
(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
|
By:
|
/s/ Richard M. Levy | |
Richard M. Levy | |||
Chief Financial Officer and Vice President - Finance | |||
SCOLR Pharma, Inc. |
Date:
November 6, 2009